IL6 and Insulin resistance: IL-6 is a cytokine that has been implicated in the pathogenesis of GDM via its pro-inflammatory impact on endothelium dysfunction and insulin resistance, suggesting that high levels of IL-6 are correlated with increased insulin resistance, leading to potentially higher blood glucose and worsening prognosis of GDM [38].